Text Size
29 studies found for:    weill | "Retroviridae Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Conditions: Anemia;   Neutropenia;   Hepatitis C Virus;   HIV Infections
Intervention: Drug: erythropoietin, GCSF
2 Completed Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
3 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
4 Completed Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
Condition: HIV Infections
Interventions: Biological: ALVAC HIV vaccine (vCP1452);   Drug: Interleukin-2
5 Completed
Has Results 		HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
6 Not yet recruiting Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
Conditions: HIV;   AIDS;   Substance Abuse
Interventions: Behavioral: Enhanced HIV Care Access and Retention Intervention;   Behavioral: HIV Testing Campaign;   Behavioral: Treatment Re-engagement Campaign;   Behavioral: Patient Navigator Linkage to Care and Substance Abuse Treatment Team;   Behavioral: Mobile Care Clinic
7 Completed A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Didanosine
8 Recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide;   Drug: elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate
9 Active, not recruiting Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: darunavir/cobicistat/emtricitabine/GS-7340;   Drug: darunavir + cobicistat + emtricitabine/tenofovir df
10 Recruiting Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Condition: Hepatitis C, Genotype 1
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: Ribavirin;   Drug: Peg-Interferon alfa 2a
11 Completed Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Serostim®[somatropin (rDNA origin) for injection]
12 Completed
Has Results 		Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
13 Completed Typology of Adherence in Adolescents: Phase II
Condition: HIV Infection
Intervention:
14 Completed Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Efavirenz
15 Completed
Has Results 		Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis C;   Liver Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
16 Completed Effect of Interleukin-2 on HIV Treatment Interruption
Condition: HIV Infections
Intervention: Drug: Aldesleukin
17 Completed Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Atazanavir;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine
18 Completed Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
Conditions: Cytomegalovirus Infections;   HIV Infections
Intervention: Drug: Valganciclovir
19 Completed Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Aldesleukin;   Drug: Peginterferon alfa-2b
20 Completed A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Adefovir dipivoxil;   Drug: Tenofovir disoproxil fumarate
To Top

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
† Indicates status has not been verified in more than two years